Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma
Titel:
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma
Auteur:
Seiwert, Tanguy Y. Wildsmith, Sophie Fayette, Jérôme Harrington, Kevin Gillison, Maura Ahn, Myung-Ju Takahashi, Shunji Weiss, Jared Machiels, Jean-Pascal Baxi, Shrujal Baker, Valerie Evans, Brent Morsli, Nassim Jill Walker, Real, Katia L’Hernault, Anne Psyrri, Amanda